Related Experiment Video
Updated: Jul 3, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Neurodevelopmental outcome in children with congenital cytomegalovirus infection: A prospective multicenter cohort
A Keymeulen1, E De Leenheer2, A Casaer3
1Department of neonatology, Ghent University Hospital Ghent, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
Insights
Congenital cytomegalovirus (cCMV) infection can lead to neurodevelopmental impairment in children. This study found that 70.4% of cCMV-infected children had normal outcomes, but risks for issues like ASD and speech impairment persist even in asymptomatic cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurodevelopmental Disorders
Background:
- Congenital cytomegalovirus (cCMV) infection is the leading cause of congenital infection globally.
- It is a significant contributor to neurodevelopmental impairments in children.
- Current data on neurodevelopmental outcomes for cCMV-infected children, both symptomatic and asymptomatic, are limited.
Purpose of the Study:
- To investigate and characterize the neurodevelopmental outcomes in a substantial prospective cohort of children diagnosed with cCMV.
- To provide comprehensive data on the long-term effects of cCMV infection on child development.
Main Methods:
- Analysis of data from 753 children within the Flemish cCMV register.
- Assessment of neuromotor, cognitive, behavioral, audiological, and ophthalmological outcomes.
- Prospective follow-up to evaluate developmental trajectories.
Main Results:
- Normal neurodevelopmental outcomes were observed in 70.4% of children.
- Mild, moderate, and severe impairments were identified in 16.9%, 7.4%, and 5.2% of cases, respectively.
- Adverse outcomes occurred in 53.5% of symptomatic and 17.8% of asymptomatic children; autism spectrum disorder (ASD) was diagnosed in 2.5% of cases, exceeding the general population rate.
Conclusions:
- Both symptomatic and asymptomatic cCMV infections pose risks for sequelae, with higher risks associated with first-trimester infections.
- Key areas for follow-up include audiology, early hypotonia, potential increased risk of ASD, and speech/language impairments, even without hearing loss.
- Multidisciplinary neurodevelopmental follow-up is crucial for all children with cCMV infection.
Background:
Congenital cytomegalovirus infection (cCMV) is the most common congenital infection worldwide and is a major cause of neurodevelopmental impairment in children. At this point there are insufficient data on neurodevelopmental outcome of children with cCMV, both symptomatic and asymptomatic.
Aim:
This study aimed to describe the neurodevelopmental outcome in a large prospective cohort of children with cCMV.
Methods:
All children with cCMV, included in the Flemish cCMV register, were eligible for this study. Data on neurodevelopmental outcome was available in 753 children. Data on neuromotor, cognitive, behavioral, audiological and ophthalmological outcome were analyzed.
Results:
Neurodevelopmental outcome was normal in 530/753 (70,4 %) at any age of last follow-up. Mild, moderate and severe neurodevelopmental impairment was found in 128/753 (16,9 %), 56/753 (7,4 %) and 39/753 (5,2 %), respectively. Adverse outcome is found both in the symptomatic and asymptomatic children (53,5 % versus 17,8 %). Autism spectrum disorder (ASD) was diagnosed more often than in the general population in Flanders (2,5 % versus 0,7 %). Speech and language impairment was found in 2 %, even in absence of hearing loss.
Conclusion:
Both symptomatic and asymptomatic cCMV children are at risk of sequelae, with higher risk in case of first trimester infection. During follow-up of this population, special attention should be given to the audiological follow-up, the presence of hypotonia at young age, the possible higher risk of ASD and the risk of speech and language impairment even in absence of hearing loss. Our results emphasize the need for multidisciplinary neurodevelopmental follow-up of all cCMV infected children.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Teratogenicity
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis